• Browse Industries
• Health Care

• FDLI SmartBrief
• News
• Press Releases
• SmartBlogs
• Topics
• FDA
• Generic drugs
• Medical devices
• Nutrition
• Stem Cells
• Vaccines
• Jobs
• View Job Listings
• Post a Job
• Job Listings FAQ's
• Most Clicked Stories
• FDLI News
• FDLI Reader Polls
• Archive
• RSS

• Find/Post Jobs

• Partner With Us

• Advertise

• About SmartBrief

• Reader Polls

Press Releases

SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results

PRNewswire | 22 hours 59 minutes ago

... (more)

Cardiome to Release Third Quarter Results

PRNewswire | 1 day 28 minutes ago

NASDAQ: CRME TSX: COM... (more)

Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2

PRNewswire | 1 day 28 minutes ago

... (more)

CardioNet, Inc. Reports Third Quarter 2009 Financial Results

Business Wire | 1 day 59 minutes ago

CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter and nine months ended September 30, 2009.... (more)

Microbix Biosystems Re-files Annual Results With OSC

PRNewswire | 1 day 2 hours 28 minutes ago

TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended September 30, 2008.... (more)

Watson to Present at Credit Suisse Healthcare Conference

PRNewswire | 1 day 2 hours 28 minutes ago

... (more)

Centene Corporation to Present at Upcoming Healthcare Conferences

PRNewswire | 1 day 2 hours 28 minutes ago

... (more)

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

PRNewswire | 1 day 2 hours 58 minutes ago

... (more)

Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc.

Business Wire | 1 day 2 hours 58 minutes ago

Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Trimeris, Inc. (“Trimeris” or the “Company”) (Nasdaq: TRMS) for possible breaches of fiduciary duty and other violations of state law in connection with an agreement by the Trimeris Board of Directors to sell all of the Company’s outstanding shares of common stock at a price of $3.60 per share to Arigene Co., Ltd. (“Arigene”).... (more)

Medtronic Receives President s E Award in Recognition of Its Support of U.S. Exports

Business Wire | 1 day 8 hours 28 minutes ago

Recognizing its significant contributions to increasing U.S. exports, Medtronic, Inc., (NYSE: MDT) received President Barack Obama’s “E” Award on Thursday, Nov. 5. The ceremony, held in the U.S. Department of Commerce, was part of the District Export Council Conference in Washington D.C. The award recognized Medtronic and other individuals and companies for their efforts in promoting and increasing U.S. exports.... (more)

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution

PRNewswire | 1 day 8 hours 29 minutes ago

... (more)

Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued Profitability

MarketWire | 1 day 8 hours 29 minutes ago

LONDON, ONTARIO -- (Marketwire) -- 11/06/09 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred. ... (more)

Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting

PRNewswire | 1 day 8 hours 58 minutes ago

... (more)

Helix BioMedix Reports Third Quarter 2009 Financial Results

Business Wire | 1 day 8 hours 58 minutes ago

Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced financial results for the third quarter ended September 30, 2009.... (more)

148 Press Releases  |   RSS Feed

Sign up for FDLI SmartBrief

Latest Blog Postsview more

Job Listingsview more

Companies in the news

© 1999-2009 SmartBrief, Inc. |  Terms of Use |  Send Feedback |  Frequently Asked Questions (FAQ) |  Privacy and Legal Information

About SmartBrief |  Advertise with SmartBrief |  Sign up for Newsletters |  Partner with SmartBrief